Actively Recruiting
Proactive Risk Evaluation for Cardiac Implantable Electronic Device Strategy Using AI-ECG
Led by National Defense Medical Center, Taiwan · Updated on 2025-12-12
11492
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn whether an artificial intelligence-enhanced electrocardiogram (AI-ECG) strategy improves timely intervention of patients requiring cardiac implantable electronic devices (CIEDs), compared with standard clinical care.
CONDITIONS
Official Title
Proactive Risk Evaluation for Cardiac Implantable Electronic Device Strategy Using AI-ECG
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least one 12-lead ECG within 1 year
You will not qualify if you...
- Diagnosis of sick sinus syndrome
- Diagnosis of high-grade or complete atrioventricular block
- Diagnosis of ventricular tachycardia or ventricular fibrillation
- Post CIED implant
- Heart rate below 40 beats per minute by 12-lead ECG
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tri-Service General Hospital
Taipei, Taiwan
Actively Recruiting
Research Team
C
Chin Lin
CONTACT
W
Wen-Yu Lin
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here